• 1
    Lee RG, Tsamandas AC, Demetris AJ. Large cell change (liver cell dysplasia) and hepatocellular carcinoma in cirrhosis: matched case-control study, pathologic analysis, and pathogenetic hypothesis. Hepatology 1997; 26:14151422.MEDLINE
  • 2
    International Working Party. Terminology of nodular hepatocellular lesions. Hepatology 1995; 22:983993.MEDLINE
  • 3
    Le Bail B, Bernard PH, Carles J, Balabaud C, Bioulac-sage P. Prevalence of liver cell dysplasia and association with HCC in a series of 100 cirrhotic explants. J Hepatol 1997; 27:835842.MEDLINE
  • 4
    LeBail B, Belleanné G, Bernard P-H, Saric J, Balabaud C, Bioulac-Sage P. Adenomatous hyperplasia in cirrhotic livers: histological evaluation, cellular density, and proliferative activity of 35 macronodular lesions in the cirrhotic explants of 10 adult French patients. Hum Pathol 1995; 26:897906.MEDLINE
  • 5
    Santoni-Rugiu E, Jensen MR, Thorgeirsson SS. Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor a. Cancer Res 1998; 58:123134.MEDLINE
  • 6
    Borzio M, Bruno S, Roncalli M, Colloredo-Mels G, Ramella G, Borzio F, Leandro G, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis. A prospective study. Gastroenterology 1995; 108:812817.MEDLINE